Older Hispanic people are "disproportionately more likely" than older White people to develop Alzheimer's, research shows

Major US health systems expect to offer Alzheimer's drug Leqembi in a few months

Quest Diagnostics launches Alzheimer's blood test for consumers

US announces trial payment program for care providers of dementia patients

Promising new Alzheimer's drugs may benefit whites more than Blacks

Lilly drug slows Alzheimer's by 60% for mildly impaired patients in trial

Alzheimer's diagnosis revamp embraces rating scale similar to cancer

Acumen's Alzheimer's drug passes initial safety test

Factbox-Companies in Alzheimer's race after US nod for Eisai/Biogen drug

Explainer-Who is eligible for the new FDA-approved Alzheimer's drug?

US FDA grants standard approval of Eisai/Biogen Alzheimer's drug

Medicare offers details on reimbursement for new Alzheimer's drugs